PAN boosts account handling team
October 15, 2010Medical Communications Pan, appointment, medical communications
UK advertising agency PAN has made two new appointments and three promotions.Andisheh Thomson joins as account manager and Natalie Enniks …
Celgene completes Abraxis takeover
October 15, 2010Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology
Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …
Video exclusive: PM Society Digital Awards 2010
October 14, 2010Medical Communications PM Society Digital Awards, awards, digi, pm society
Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …
Researchers unearth Pfizer’s buried data
October 14, 2010Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data
Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
Philip Loder joins Alpha-Plus Medical Communications
October 14, 2010Medical Communications Alpha-Plus, Alpha-Plus Medical Communications, Client Service Director, appointment, fishawack, medical communications
High Wycombe, UK-based Alpha-Plus Medical Communications has appointed Dr Phil Loder as client service director. He has 16 years of …
Pharma manufacturing news in brief
October 14, 2010Manufacturing and Production Accucaps, Fresenius Kabi, ImmunoCellular Therapeutics, Laureate Pharma, SAFC Pharma
This week’s round-up of pharmaceutical manufacturing news includes a recall for Fresenius Kabi, facility updates from SAFC and Laureate Pharma …
NICE rejects GSK Tyverb appeal
October 14, 2010Sales and Marketing GlaxoSmithKline, NICE, Tyverb
NICE’s independent appeal board has ruled the UK drug’s watchdog did not exceed its powers when issuing guidance on GlaxoSmithKline’s …
Merck Serono eyes ‘Nanobody’ potential in rheumatology
October 14, 2010Research and Development Ablynx, Merck Serono
Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
UK invests £50m in targeted research
October 13, 2010Research and Development BIA, clinical research, genomics, personalised medicine, targeting
The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
China driving global pharma growth
October 13, 2010Sales and Marketing China, emerging markets, sales
The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …
Pfizer acquires King Pharmaceuticals for $3.6bn
October 13, 2010Sales and Marketing King Pharmaceuticals, Pfizer, pain therapeutics
Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …
NICE unmoved on Takeda bone cancer drug
October 13, 2010Sales and Marketing Mepact, NICE, Takeda
NICE has refused to recommend Takeda’s Mepact because of its “exceptionally high cost” and the “substantial uncertainty” about the osteosarcoma …
Philip Vickers joins Shire
October 13, 2010Research and Development Shire, appointment, research and development
Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Digital Pharma: Genzyme’s augmented reality heart
October 12, 2010Medical Communications Digital Pharma blog, Genzyme, augmented reality
Genzyme Europe has launched a new website that allows users to take a peak inside their own heart, or so …
Pharmsynthez boosts board
October 12, 2010Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development
Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …
UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Stem cell trial re-starts
October 12, 2010Research and Development Geron, Stem cells, spinal injury
Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
Making the most of outsourcing and offshoring
October 12, 2010Manufacturing and Production, Research and Development Kinapse, outsourcing
As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Merck will appeal EMA’s Movectro decision
October 12, 2010Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro
Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …
UniversalProcon expands UK team
October 11, 2010Sales and Marketing UniversalProcon, appointment, sales and marketing
Transatlantic event management company UniversalProcon has expanded its UK operations with five new appointments. Sophie Limbert (pictured) joins as a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
